Laigo Bio is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary SureTAC platform. The company utilizes bispecific antibodies to…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Laigo Bio →Already a subscriber? Sign in
Xcout Intel tracks Laigo Bio continuously — this profile deepens as new filings, funding, people and hiring data arrive.